Halozyme Therapeutics, Inc. (HALO)
61.90
-0.75
(-1.20%)
USD |
NASDAQ |
Dec 11, 16:00
61.91
+0.01
(+0.02%)
After-Hours: 20:00
Halozyme Therapeutics EPS Diluted (TTM): 4.757 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Merck & Co., Inc. | 7.560 |
| ANI Pharmaceuticals, Inc. | 1.631 |
| Bristol Myers Squibb Co. | 2.962 |
| Twist Bioscience Corp. | -1.309 |
| Aurinia Pharmaceuticals, Inc. | 0.5611 |